Cargando…
Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267111/ https://www.ncbi.nlm.nih.gov/pubmed/34137814 http://dx.doi.org/10.1182/bloodadvances.2021005072 |
Ejemplares similares
-
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database
por: Liu, Xin, et al.
Publicado: (2023) -
Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG)
por: Liu, Wei-Xin, et al.
Publicado: (2019) -
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
por: Yang, Yong, et al.
Publicado: (2020) -
Risk‐dependent curability of radiotherapy for elderly patients with early‐stage extranodal nasal‐type NK/T‐cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)
por: Chen, Bo, et al.
Publicado: (2018) -
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
por: Li, Jia-Ying, et al.
Publicado: (2023)